494 results
Search Results
2. Research Paper: Immune Checkpoint Molecules in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
- Author
-
Monabati, Ahmad, Nematollahi, Pardis, Dehghanian, Amirreza, Safaei, Akbar, Sadeghipour, Alireza, Movahedinia, Sajjadeh, and Mokhtari, Maral
- Subjects
- *
CENTRAL nervous system , *DIFFUSE large B-cell lymphomas , *PROGRAMMED cell death 1 receptors , *PROGRAMMED death-ligand 1 , *HEMATOLOGIC malignancies , *LYMPHOMAS - Abstract
Introduction: Primary Diffuse Large B Cell Lymphoma of CNS (PCNSL) is a rare variant of Diffuse Large B Cell Lymphoma (DLBCL) and presents with an aggressive clinical course and usually resistant to commonly used therapy regimens. Recently, role of immune checkpoint molecules including PD-1 and PD-L1 confirmed in some solid tumors and lymphoma resulting tumor cells escape the immune system and help to survive and to spread. Inhibitors of PD-1 and PD-L1 have shown lasting responses in several solid and some hematological tumors, while limited studies evaluate checkpoint molecules on PCNSL. Method: In this study, we investigated PD-1 and PD-L1 expression by immunostaining on 71 patients with PCNSL and correlation with demographic data, location of the tumor, proliferation rate, cell of origin, and CD8 positive T cell infiltration in tumor microenvironment. Results: 16 from71 showed PD-1 expression, while PD-L1 expression were 42/71. No association was determined between PD-1/PD-L1 expression and gender, cell of origin, and proliferation rate, but a highly significant difference was determined between the infiltration of CD8 positive T cells in two groups of PD-1/PD-L1 positive and negative. Conclusion: This study revealed expression of check point molecules in remarkable number of PCNSL which may open new therapeutic recommendations in this aggressive lymphoma type. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
3. Research Paper: Comparison of the Position Sense of the Knee Joint in Patients With Multiple Sclerosis and Healthy Controls.
- Author
-
Aliabadi, Saina, Khanmohammadi, Roya, Olyaei, Gholamrezareza, Ghotbi, Nastaran, Talebian, Saeed, and Moghadasi, Abdolreza Naser
- Subjects
- *
PATIENTS , *MULTIPLE sclerosis , *CENTRAL nervous system , *PROPRIOCEPTION , *TUBEROUS sclerosis - Abstract
Introduction: Position sense, one of the most accurate senses in the body, makes everyone aware of the state of the body in space. This sense is an essential ability in maintaining physical health and avoiding injury. Deficits in position sense cause balance impairments in people with mild Multiple Sclerosis (MS). Position sense requires instant and coordinated communication between the central nervous system and peripheral nervous system, while in patients with MS, communication between the brain and other parts of the body is disrupted. This study aims to compare the position sense of knee joint in people with MS and healthy subjects. Materials and Methods: Ten healthy subjects with the Mean±SD age of 27.6±3.71 years and 10 persons with MS disease and the Mean±SD age of 31.40±3.50 years participated in this study. For evaluating their position sense of knee joint, they flexed their knees (from 90 to 45 degrees) four times, and then a software calculated their repositioning errors. Results: No significant changes in repositioning errors (constant, variable, absolute) were observed in MS patients, and the control group (P˃0.05). Conclusion: The results indicate that mild MS disease cannot disturb the position sense of knee joint. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
4. Aided Diagnosis Model Based on Deep Learning for Glioblastoma, Solitary Brain Metastases, and Primary Central Nervous System Lymphoma with Multi-Modal MRI.
- Author
-
Liu, Xiao and Liu, Jie
- Subjects
- *
DEEP learning , *CENTRAL nervous system , *CINGULATE cortex , *CANCER diagnosis , *DIAGNOSIS , *MAGNETIC resonance imaging ,CENTRAL nervous system tumors - Abstract
Simple Summary: Diagnosing glioblastoma multiforme (GBM), solitary brain metastases (SBM), and primary central nervous system lymphoma (PCNSL) in malignant tumors of the central nervous system using multi-modal magnetic resonance imaging (MRI) is significantly important in helping physicians develop treatment plans and enhance patient prognosis. In this paper, MFFC-Net is developed and validated using deep learning methods to predict these three tumor categories from multi-modal MRI without the manual region of interest (ROI). MFFC-Net first uses a multi-encoder with DenseBlocks to extract deep features from multi-modal MRI. Then, the feature fusion layer fuses the deep information between different modalities and tissues. Finally, the spatial-channel attention module suppresses redundant new information and activates tumor classification-related features. Compared with radiomics models, MFFC-Net demonstrated higher accuracy. In addition, the results in the different sequences provide important references for future clinical work on MRI image acquisition. We believe that MFFC-Net has the potential to assist in the diagnosis and treatment of brain tumors in the future. (1) Background: Diagnosis of glioblastoma (GBM), solitary brain metastases (SBM), and primary central nervous system lymphoma (PCNSL) plays a decisive role in the development of personalized treatment plans. Constructing a deep learning classification network to diagnose GBM, SBM, and PCNSL with multi-modal MRI is important and necessary. (2) Subjects: GBM, SBM, and PCNSL were confirmed by histopathology with the multi-modal MRI examination (study from 1225 subjects, average age 53 years, 671 males), 3.0 T T2 fluid-attenuated inversion recovery (T2-Flair), and Contrast-enhanced T1-weighted imaging (CE-T1WI). (3) Methods: This paper introduces MFFC-Net, a classification model based on the fusion of multi-modal MRIs, for the classification of GBM, SBM, and PCNSL. The network architecture consists of parallel encoders using DenseBlocks to extract features from different modalities of MRI images. Subsequently, an L 1 − n o r m feature fusion module is applied to enhance the interrelationships among tumor tissues. Then, a spatial-channel self-attention weighting operation is performed after the feature fusion. Finally, the classification results are obtained using the full convolutional layer (FC) and Soft-max. (4) Results: The ACC of MFFC-Net based on feature fusion was 0.920, better than the radiomics model (ACC of 0.829). There was no significant difference in the ACC compared to the expert radiologist (0.920 vs. 0.924, p = 0.774). (5) Conclusions: Our MFFC-Net model could distinguish GBM, SBM, and PCNSL preoperatively based on multi-modal MRI, with a higher performance than the radiomics model and was comparable to radiologists. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. The people behind the papers - Wael Noor El-Nachef and Marianne Bronner.
- Subjects
- *
ENTERIC nervous system , *NEURAL crest , *GASTROINTESTINAL system , *CENTRAL nervous system , *DEVELOPMENTAL biology - Published
- 2020
- Full Text
- View/download PDF
6. The Emerging Role of Microglial Hv1 as a Target for Immunomodulation in Myelin Repair.
- Author
-
Yingxin Tang, Xuan Wu, Jiarui Li, Yuanwei Li, Xiaoxiao Xu, Gaigai Li, Ping Zhang, Chuan Qin, Long-Jun Wu, Zhouping Tang, and Dai-Shi Tian
- Subjects
- *
MICROGLIA , *IMMUNOREGULATION , *CENTRAL nervous system - Abstract
In the central nervous system (CNS), the myelin sheath ensures efficient interconnection between neurons and contributes to the regulation of the proper function of neuronal networks. The maintenance of myelin and the well-organized subtle process of myelin plasticity requires cooperation among myelin-forming cells, glial cells, and neural networks. The process of cooperation is fragile, and the balance is highly susceptible to disruption by microenvironment influences. Reactive microglia play a critical and complicated role in the demyelination and remyelination process. Recent studies have shown that the voltage-gated proton channel Hv1 is selectively expressed in microglia in CNS, which regulates intracellular pH and is involved in the production of reactive oxygen species, underlying multifaceted roles in maintaining microglia function. This paper begins by examining the molecular mechanisms of demyelination and emphasizes the crucial role of the microenvironment in demyelination. It focuses specifically on the role of Hv1 in myelin repair and its therapeutic potential in CNS demyelinating diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. The role of annexins in central nervous system development and disease.
- Author
-
White II, Zachary B., Nair, Sindhu, and Bredel, Markus
- Subjects
- *
CENTRAL nervous system diseases , *ANNEXINS , *CENTRAL nervous system viral diseases , *ALZHEIMER'S disease , *CELL membranes , *CENTRAL nervous system ,CENTRAL nervous system tumors - Abstract
Annexins, a group of Ca2+-dependent phospholipid-binding proteins, exert diverse roles in neuronal development, normal central nervous system (CNS) functioning, neurological disorders, and CNS tumors. This paper reviews the roles of individual annexins (A1-A13) in these contexts. Annexins possess unique structural and functional features, such as Ca2+-dependent binding to phospholipids, participating in membrane organization, and modulating cell signaling. They are implicated in various CNS processes, including endocytosis, exocytosis, and stabilization of plasma membranes. Annexins exhibit dynamic roles in neuronal development, influencing differentiation, proliferation, and synaptic formation in CNS tissues. Notably, annexins such as ANXA1 and ANXA2 play roles in apoptosis and blood-brain barrier (BBB) integrity. Neurological disorders, including Alzheimer's disease, multiple sclerosis, and depression, involve annexin dysregulation, influencing neuroinflammation, blood-brain barrier integrity, and stress responses. Moreover, annexins contribute to the pathogenesis of CNS tumors, either promoting or suppressing tumor growth, angiogenesis, and invasion. Annexin expression patterns vary across different CNS tumor types, providing potential prognostic markers and therapeutic targets. This review underscores the multifaceted roles of annexins in the CNS, highlighting their importance in normal functioning, disease progression, and potential therapeutic interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Multifunctional roles of γ-enolase in the central nervous system: more than a neuronal marker.
- Author
-
Horvat, Selena, Kos, Janko, and Pišlar, Anja
- Subjects
- *
CENTRAL nervous system , *ALZHEIMER'S disease , *SCAFFOLD proteins , *NEURONS , *NEUROLOGICAL disorders - Abstract
Enolase, a multifunctional protein with diverse isoforms, has generally been recognized for its primary roles in glycolysis and gluconeogenesis. The shift in isoform expression from α-enolase to neuron-specific γ-enolase extends beyond its enzymatic role. Enolase is essential for neuronal survival, differentiation, and the maturation of neurons and glial cells in the central nervous system. Neuron-specific γ-enolase is a critical biomarker for neurodegenerative pathologies and neurological conditions, not only indicating disease but also participating in nerve cell formation and neuroprotection and exhibiting neurotrophic-like properties. These properties are precisely regulated by cysteine peptidase cathepsin X and scaffold protein γ1-syntrophin. Our findings suggest that γ-enolase, specifically its C-terminal part, may offer neuroprotective benefits against neurotoxicity seen in Alzheimer's and Parkinson's disease. Furthermore, although the therapeutic potential of γ-enolase seems promising, the effectiveness of enolase inhibitors is under debate. This paper reviews the research on the roles of γ-enolase in the central nervous system, especially in pathophysiological events and the regulation of neurodegenerative diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology.
- Author
-
Thompson, Landon John-Patrick, Genovese, Jessica, Hong, Zhenzi, Singh, Meera Vir, and Singh, Vir Bahadur
- Subjects
- *
NEUROBEHAVIORAL disorders , *CELLULAR pathology , *BLOOD-brain barrier , *TAT protein , *HIV-1 glycoprotein 120 , *MOLECULAR pathology , *CENTRAL nervous system - Abstract
Despite combined antiretroviral therapy (cART) limiting HIV replication to undetectable levels in the blood, people living with HIV continue to experience HIV-associated neurocognitive disorder (HAND). HAND is associated with neurocognitive impairment, including motor impairment, and memory loss. HIV has been detected in the brain within 8 days of estimated exposure and the mechanisms for this early entry are being actively studied. Once having entered into the central nervous system (CNS), HIV degrades the blood–brain barrier through the production of its gp120 and Tat proteins. These proteins are directly toxic to endothelial cells and neurons, and propagate inflammatory cytokines by the activation of immune cells and dysregulation of tight junction proteins. The BBB breakdown is associated with the progression of neurocognitive disease. One of the main hurdles for treatment for HAND is the latent pool of cells, which are insensitive to cART and prolong inflammation by harboring the provirus in long-lived cells that can reactivate, causing damage. Multiple strategies are being studied to combat the latent pool and HAND; however, clinically, these approaches have been insufficient and require further revisions. The goal of this paper is to aggregate the known mechanisms and challenges associated with HAND. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. The Canadian Breast Cancer Symposium 2023 Meeting Report.
- Author
-
Cil, Tulin, Boileau, Jean-François, Chia, Stephen, DeCoteau, MJ, Jerzak, Katarzyna J., Koch, Anne, Nixon, Nancy, Quan, May Lynn, Roberts, Amanda, and Brezden-Masley, Christine
- Subjects
- *
BREAST cancer , *MEDICAL personnel , *CENTRAL nervous system , *ONCOLOGIC surgery , *DUCTAL carcinoma , *CARCINOMA in situ , *EXPERIMENTAL medicine , *ONCOLOGY nursing - Abstract
On 15–16 June 2023, healthcare professionals and breast cancer patients and advocates from across Canada met in Toronto, Ontario, for the 2023 Canadian Breast Cancer Symposium (CBSC.). The CBSC. is a national, multidisciplinary event that occurs every 2 years with the goal of developing a personalized approach to the management of breast cancer in Canada. Experts provided state-of-the-art information to help optimally manage breast cancer patients, including etiology, prevention, diagnosis, experimental biology, and therapy of breast cancer and premalignant breast disease. The symposium also had the objectives of increasing communication and collaboration among breast cancer healthcare providers nationwide and providing a comprehensive and real-life review of the many facets of breast cancer. The sessions covered the patient voice, the top breast cancer papers from different disciplines in 2022, artificial intelligence in breast cancer, systemic therapy updates, the management of central nervous system metastases, multidisciplinary management of ductal carcinoma in situ, special populations, optimization-based individual prognostic factors, toxicity management of novel therapeutics, survivorship, and updates in surgical oncology. The key takeaways of these sessions have been summarized in this conference report. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Electroacupuncture stimulation enhances the permeability of the blood-brain barrier: A systematic review and meta-analysis of preclinical evidence and possible mechanisms.
- Author
-
Xu, Nuo, Gong, Peng, Xu, Shiting, Chen, Yangyun, Dai, Mengyuan, Jia, Zhaoxing, and Lin, Xianming
- Subjects
- *
BLOOD-brain barrier , *GLIAL fibrillary acidic protein , *ELECTROACUPUNCTURE , *VASCULAR endothelial growth factors , *NERVE growth factor , *CENTRAL nervous system - Abstract
An important cellular barrier to maintain the stability of the brain's internal and external environment is the blood-brain barrier (BBB). It also prevents harmful substances from entering brain tissue through blood circulation while providing protection for the central nervous system. It should be noted, however, that the intact BBB can be a barrier to the transport of most drugs into the brain via the conventional route of administration, which can prevent them from reaching effective concentrations for the treatment of disorders affecting the central nervous system. Electroacupuncture stimulation has been shown to be effective at opening the BBB in a series of experimental studies. This study systematically analyzes the possibility and mechanism by which electroacupuncture opens the BBB. In PubMed, Web of Science, VIP Database, Wanfang Database, and the Chinese National Knowledge Infrastructure, papers have been published for nearly 22 years aimed at opening the BBB and its associated structures. A comparison of EB content between electroacupuncture and control was selected as the primary outcome. There were also results on vascular endothelial growth factor (VEGF), nerve growth factor (NGF), P-Glycoprotein (P-gp), Matrix Metalloproteinase 9 (MMP-9), and glial fibrillary acidic protein (GFAP). We utilized Review Manager software analysis to analyze correlations between studies with a view to exploring the mechanisms of similarity. Evans Blue infiltration forest plot: pooled effect size of 2.04, 95% CI: 1.21 to 2.87, P < 0.01. These results indicate that electroacupuncture significantly increases EB penetration across the BBB. Most studies have reported that GFAP, MMP-9, and VEGF were upregulated after treatment. P-gp expression decreased as well. Electroacupuncture can open the BBB, and the sparse-dense wave is currently the most effective electroacupuncture frequency for opening the BBB. VEGF plays an important role in opening the BBB. It is also important to regulate the expression of MMP-9 and GFAP and inhibit the expression of P-gp. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Synthesis and Characterization of ZIF-90 Nanoparticles as Potential Brain Cancer Therapy.
- Author
-
Monarca, Lorenzo, Ragonese, Francesco, Sabbatini, Paola, Caglioti, Concetta, Stamegna, Matteo, Palazzetti, Federico, Sportoletti, Paolo, Costantino, Ferdinando, and Fioretti, Bernard
- Subjects
- *
BRAIN cancer , *CANCER treatment , *NANOPARTICLES , *CENTRAL nervous system , *DRUG therapy - Abstract
Human glioblastoma is probably the most malignant and aggressive among cerebral tumors, of which it represents approximately 80% of the reported cases, with an overall survival rate that is quite low. Current therapies include surgery, chemotherapy, and radiotherapy, with associated consistent side effects and low efficacy. The hardness in reaching the site of action, and overcoming the blood–brain barrier, is a major limitation of pharmacological treatments. In this paper, we report the synthesis and characterization of ZIF-90 (ZIF, Zeolitic Imidazolate Framework) nanoparticles as putative carriers of anticancer drugs to the brain. In particular, we successfully evaluated the biocompatibility of these nanoparticles, their stability in body fluids, and their ability to uptake in U251 human glioblastoma cell lines. Furthermore, we managed to synthesize ZIF-90 particles loaded with berberine, an alkaloid reported as a possible effective adjuvant in the treatment of glioblastoma. These findings could suggest ZIF-90 as a possible new strategy for brain cancer therapy and to study the physiological processes present in the central nervous system. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders.
- Author
-
Agosti, Edoardo, Zeppieri, Marco, Antonietti, Sara, Battaglia, Luigi, Ius, Tamara, Gagliano, Caterina, Fontanella, Marco Maria, and Panciani, Pier Paolo
- Subjects
- *
CENTRAL nervous system , *INTRANASAL administration , *NANOCARRIERS , *BLOOD-brain barrier , *ALZHEIMER'S disease , *INTRANASAL medication , *LIPIDS - Abstract
Background: The blood–brain barrier (BBB) regulates brain substance entry, posing challenges for treating brain diseases. Traditional methods face limitations, leading to the exploration of non-invasive intranasal drug delivery. This approach exploits the direct nose-to-brain connection, overcoming BBB restrictions. Intranasal delivery enhances drug bioavailability, reduces dosage, and minimizes systemic side effects. Notably, lipid nanoparticles, such as solid lipid nanoparticles and nanostructured lipid carriers, offer advantages like improved stability and controlled release. Their nanoscale size facilitates efficient drug loading, enhancing solubility and bioavailability. Tailored lipid compositions enable optimal drug release, which is crucial for chronic brain diseases. This review assesses lipid nanoparticles in treating neuro-oncological and neurodegenerative conditions, providing insights for effective nose-to-brain drug delivery. Methods: A systematic search was conducted across major medical databases (PubMed, Ovid MEDLINE, and Scopus) up to 6 January 2024. The search strategy utilized relevant Medical Subject Heading (MeSH) terms and keywords related to "lipid nanoparticles", "intranasal administration", "neuro-oncological diseases", and "neurodegenerative disorders". This review consists of studies in vitro, in vivo, or ex vivo on the intranasal administration of lipid-based nanocarriers for the treatment of brain diseases. Results: Out of the initial 891 papers identified, 26 articles met the eligibility criteria after a rigorous analysis. The exclusion of 360 articles was due to reasons such as irrelevance, non-reporting selected outcomes, the article being a systematic literature review or meta-analysis, and lack of method/results details. This systematic literature review, focusing on nose-to-brain drug delivery via lipid-based nanocarriers for neuro-oncological, neurodegenerative, and other brain diseases, encompassed 60 studies. A temporal distribution analysis indicated a peak in research interest between 2018 and 2020 (28.3%), with a steady increase over time. Regarding drug categories, Alzheimer's disease was prominent (26.7%), followed by antiblastic drugs (25.0%). Among the 65 drugs investigated, Rivastigmine, Doxorubicin, and Carmustine were the most studied (5.0%), showcasing a diverse approach to neurological disorders. Notably, solid lipid nanoparticles (SLNs) were predominant (65.0%), followed by nanostructured lipid carriers (NLCs) (28.3%), highlighting their efficacy in intranasal drug delivery. Various lipids were employed, with glyceryl monostearate being prominent (20.0%), indicating preferences in formulation. Performance assessment assays were balanced, with in vivo studies taking precedence (43.3%), emphasizing the translation of findings to complex biological systems for potential clinical applications. Conclusions: This systematic review reveals the transformative potential of intranasal lipid nanoparticles in treating brain diseases, overcoming the BBB. Positive outcomes highlight the effectiveness of SLNs and NLCs, which are promising new approaches for ailments from AD to stroke and gliomas. While celebrating progress, addressing challenges like nanoparticle toxicity is also crucial. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Photobiomodulation for Neurodegenerative Diseases: A Scoping Review.
- Author
-
Shen, Qi, Guo, Haoyun, and Yan, Yihua
- Subjects
- *
NEURODEGENERATION , *PHOTOBIOMODULATION therapy , *ALZHEIMER'S disease , *PARKINSON'S disease , *CENTRAL nervous system - Abstract
Neurodegenerative diseases involve the progressive dysfunction and loss of neurons in the central nervous system and thus present a significant challenge due to the absence of effective therapies for halting or reversing their progression. Based on the characteristics of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), which have prolonged incubation periods and protracted courses, exploring non-invasive physical therapy methods is essential for alleviating such diseases and ensuring that patients have an improved quality of life. Photobiomodulation (PBM) uses red and infrared light for therapeutic benefits and functions by stimulating, healing, regenerating, and protecting organizations at risk of injury, degradation, or death. Over the last two decades, PBM has gained widespread recognition as a non-invasive physical therapy method, showing efficacy in pain relief, anti-inflammatory responses, and tissue regeneration. Its application has expanded into the fields of neurology and psychiatry, where extensive research has been conducted. This paper presents a review and evaluation of studies investigating PBM in neurodegenerative diseases, with a specific emphasis on recent applications in AD and PD treatment for both animal and human subjects. Molecular mechanisms related to neuron damage and cognitive impairment are scrutinized, offering valuable insights into PBM's potential as a non-invasive therapeutic strategy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Distribution of Monocarboxylate Transporters in Brain and Choroid Plexus Epithelium.
- Author
-
Ueno, Masaki, Chiba, Yoichi, Murakami, Ryuta, Miyai, Yumi, Matsumoto, Koichi, Wakamatsu, Keiji, Takebayashi, Genta, Uemura, Naoya, and Yanase, Ken
- Subjects
- *
MONOCARBOXYLATE transporters , *CHOROID plexus , *GLUCOSE transporters , *EPITHELIUM , *CENTRAL nervous system - Abstract
The choroid plexus (CP) plays central roles in regulating the microenvironment of the central nervous system by secreting the majority of cerebrospinal fluid (CSF) and controlling its composition. A monolayer of epithelial cells of CP plays a significant role in forming the blood–CSF barrier to restrict the movement of substances between the blood and ventricles. CP epithelial cells are equipped with transporters for glucose and lactate that are used as energy sources. There are many review papers on glucose transporters in CP epithelial cells. On the other hand, distribution of monocarboxylate transporters (MCTs) in CP epithelial cells has received less attention compared with glucose transporters. Some MCTs are known to transport lactate, pyruvate, and ketone bodies, whereas others transport thyroid hormones. Since CP epithelial cells have significant carrier functions as well as the barrier function, a decline in the expression and function of these transporters leads to a poor supply of thyroid hormones as well as lactate and can contribute to the process of age-associated brain impairment and pathophysiology of neurodegenerative diseases. In this review paper, recent findings regarding the distribution and significance of MCTs in the brain, especially in CP epithelial cells, are summarized. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. Autoimmune Encephalitis with Antibodies: Anti-NMDAR, Anti-AMPAR, Anti-GQ1b, Anti-DPPX, Anti-CASPR2, Anti-LGI1, Anti-RI, Anti-Yo, Anti-Hu, Anti-CV2 and Anti-GABAAR, in the Course of Psychoses, Neoplastic Diseases, and Paraneoplastic Syndromes.
- Author
-
Braczkowski, Michał, Soszyński, Dariusz, Sierakowska, Alicja, Braczkowski, Ryszard, Kufel, Klaudia, and Łabuz-Roszak, Beata
- Subjects
- *
ANTI-NMDA receptor encephalitis , *PARANEOPLASTIC syndromes , *PSYCHOSES , *CELL surface antigens , *CENTRAL nervous system , *GLUTAMATE receptors - Abstract
Encephalitis is a condition with a variety of etiologies, clinical presentations, and degrees of severity. The causes of these disorders include both neuroinfections and autoimmune diseases in which host antibodies are pathologically directed against self-antigens. In autoimmune encephalitis, autoantibodies are expressed in the central nervous system. The incidence of this disease is approximately 4% of all reported cases of encephalitis. Autoimmune encephalitis can be induced by antibodies against neuronal surface antigens such as N-methyl-D-aspartate-activated glutamate receptors (NMDAR), α-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors (AMPAR) or gangliosides GQ1b, DPPX, CASPR2, LGI1, as well as by antibodies against neuronal intracellular antigens. The paper presents a number of both mental and neurological symptoms of autoimmune encephalitis. Moreover, the coexistence of psychoses, neoplastic diseases, and the methods of diagnosing autoimmune encephalitis are discussed. Attention was also drawn to the fact that early diagnosis, as well as early initiation of targeted treatment, increases the chance of a successful course of the therapeutic process. Strategy and Methodology: The articles on which the following paper was based were searched using search engines such as PubMed and Medline. Considering that anti-NMDAR antibodies were first described in 2007, the articles were from 2007 to 2023. The selection of papers was made by entering the phrases "autoimmune encephalitis and psychosis/paraneplastic syndromes or cancer". The total number of articles that could be searched was 747, of which 100 items were selected, the most recent reports illustrating the presented topic. Thirty-four of them were rejected in connection with case reports or papers that could not be accessed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. The neurovascular syndromes: A review of pathophysiology - Lessons learnt from Prof. Chandy's paper published in 1989.
- Author
-
Bhatoe, Harjinder and Bhatoe, Harjinder S
- Subjects
- *
ACOUSTIC nerve , *PERIPHERAL nervous system , *FACIAL pain , *NEUROANATOMY , *TRIGEMINAL neuralgia , *CENTRAL nervous system , *NEUROSCIENCES , *ENTRAPMENT neuropathies ,VASCULAR disease diagnosis - Abstract
The article focuses on the study of neurovascular syndromes. It mentions that pulsatile propulsion of blood through blood vessels help in the circulation and transport of oxygen and nutrients. It mentions that pulsatile impulse by the heart in the cardiac cycle improves the pressure-related events to capillaries.
- Published
- 2019
- Full Text
- View/download PDF
18. Exercise and Weight Management: The Role of Leptin—A Systematic Review and Update of Clinical Data from 2000–2022.
- Author
-
de Assis, Gilmara Gomes and Murawska-Ciałowicz, Eugenia
- Subjects
- *
LEPTIN , *REGULATION of body weight , *ADIPOSE tissues , *INGESTION disorders , *LEPTIN receptors , *CENTRAL nervous system - Abstract
A well-balanced metabolism means a lower risk for metabolism-related neuropsychiatric disorders. Leptin is a secretory adipokine involved in the central control of appetite that appears to play a role in the etiology of feeding-related disorders. Additionally, the influence of exercise on feeding behaviors potentially modulates the circulation of metabolites that signal through the central nervous system. In this systematic review, we collected the recent clinical evidence on the effect of exercise on leptin concentrations in health individuals published from 2000 to 20 September 2022, according to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA 2020 statement). Six hundred and thirty-eight papers were retrieved and forty-eight papers were included in the qualitative synthesis. Data supports that exercise positively influences appetite via enhancing peripheral and central leptin signaling (reuptake), especially during weight loss. Exercise modulation of leptin signaling through leptin receptors helps to stabilize increases in food intake during periods of negative energy balance, prior to a decrease in the body fat tissue content. At a high intensity, exercise appears to counteract leptin resistance. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. The Brain's Glymphatic System: Drawing New Perspectives in Neuroscience.
- Author
-
Ciurea, Alexandru Vlad, Mohan, Aurel George, Covache-Busuioc, Razvan-Adrian, Costin, Horia Petre, and Saceleanu, Vicentiu Mircea
- Subjects
- *
ALZHEIMER'S disease , *CENTRAL nervous system , *NEUROSCIENCES , *CIRCADIAN rhythms , *CEREBROSPINAL fluid , *BRAIN imaging , *CHRONIC traumatic encephalopathy - Abstract
This paper delves into the intricate structure and functionality of the brain's glymphatic system, bringing forth new dimensions in its neuroscientific understanding. This paper commences by exploring the cerebrospinal fluid (CSF)—its localization, production, and pivotal role within the central nervous system, acting as a cushion and vehicle for nutrient distribution and waste elimination. We then transition into an in-depth study of the morphophysiological aspects of the glymphatic system, a recent discovery revolutionizing the perception of waste clearance from the brain, highlighting its lymphatic-like characteristics and remarkable operations. This paper subsequently emphasizes the glymphatic system's potential implications in Alzheimer's disease (AD), discussing the connection between inefficient glymphatic clearance and AD pathogenesis. This review also elucidates the intriguing interplay between the glymphatic system and the circadian rhythm, illustrating the optimal functioning of glymphatic clearance during sleep. Lastly, we underscore the hitherto underappreciated involvement of the glymphatic system in the tumoral microenvironment, potentially impacting tumor growth and progression. This comprehensive paper accentuates the glymphatic system's pivotal role in multiple domains, fostering an understanding of the brain's waste clearance mechanisms and offering avenues for further research into neuropathological conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. RESEARCH PAPER:Coherent but overlapping expression of microRNAs and their targets during vertebrate development.
- Author
-
Shkumatava, Alena, Stark, Alexander, Sive, Hazel, and Bartel, David P.
- Subjects
- *
MESSENGER RNA , *GENE expression , *RNA synthesis , *FLOW cytometry , *VERTEBRATES , *CENTRAL nervous system - Abstract
MicroRNAs (miRNAs) are small noncoding RNAs that direct post-transcriptional repression of protein-coding genes. In vertebrates, each highly conserved miRNA typically regulates hundreds of target mRNAs. However, the precise relationship between expression of the miRNAs and that of their targets has remained unclear, in part because of the scarcity of quantitative expression data at cellular resolution. Here we report quantitative analyses of mRNA levels in miRNA-expressing cells of the zebrafish embryo, capturing entire miRNA expression domains, purified to cellular resolution using fluorescent-activated cell sorting (FACS). Focus was on regulation by miR-206 and miR-133 in the developing somites and miR-124 in the developing central nervous system. Comparison of wild-type embryos and those lacking miRNAs revealed predicted targets that responded to the miRNAs and distinguished miRNA-mediated mRNA destabilization from other regulatory effects. For all three miRNAs examined, expression of the miRNAs and that of their predicted targets usually overlapped. A few targets were expressed at higher levels in miRNA-expressing cells than in the rest of the embryo, demonstrating that miRNA-mediated repression can act in opposition to other regulatory processes. However, for most targets expression was lower in miRNA-expressing cells than in the rest of the embryo, indicating that miRNAs usually operate in concert with the other regulatory machinery of the cell. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
21. Astroglial Cells: Emerging Therapeutic Targets in the Management of Traumatic Brain Injury.
- Author
-
Czyżewski, Wojciech, Mazurek, Marek, Sakwa, Leon, Szymoniuk, Michał, Pham, Jennifer, Pasierb, Barbara, Litak, Jakub, Czyżewska, Ewa, Turek, Michał, Piotrowski, Bartłomiej, Torres, Kamil, and Rola, Radosław
- Subjects
- *
BRAIN injuries , *DRUG target , *CONNEXIN 43 , *MONOCLONAL antibodies , *CENTRAL nervous system , *NEURAL stem cells , *NERVE tissue - Abstract
Traumatic Brain Injury (TBI) represents a significant health concern, necessitating advanced therapeutic interventions. This detailed review explores the critical roles of astrocytes, key cellular constituents of the central nervous system (CNS), in both the pathophysiology and possible rehabilitation of TBI. Following injury, astrocytes exhibit reactive transformations, differentiating into pro-inflammatory (A1) and neuroprotective (A2) phenotypes. This paper elucidates the interactions of astrocytes with neurons, their role in neuroinflammation, and the potential for their therapeutic exploitation. Emphasized strategies encompass the utilization of endocannabinoid and calcium signaling pathways, hormone-based treatments like 17β-estradiol, biological therapies employing anti-HBGB1 monoclonal antibodies, gene therapy targeting Connexin 43, and the innovative technique of astrocyte transplantation as a means to repair damaged neural tissues. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. The modulatory role of gut microbiota on host behavior: exploring the interaction between the brain-gut axis and the neuroendocrine system.
- Author
-
Awe, Temitope, Fasawe, Ayoola, Sawe, Caleb, Ogunware, Adedayo, Jamiu, Abdullahi Temitope, and Allen, Michael
- Subjects
- *
GUT microbiome , *NEUROENDOCRINE system , *MICROBIAL communities , *CENTRAL nervous system , *GASTROINTESTINAL system - Abstract
The brain-gut axis refers to the communication between the central nervous system and the gastrointestinal tract, with the gut microbiome playing a crucial role. While our understanding of the interaction between the gut microbiome and the host's physiology is still in its nascent stage, evidence suggests that the gut microbiota can indeed modulate host behavior. Understanding the specific mechanisms by which the gut microbiota community modulates the host's behavior remains the focus of present and future neuro-gastroenterology studies. This paper reviews several pieces of evidence from the literature on the impact of gut microbiota on host behavior across animal taxa. We explore the different pathways through which this modulation occurs, with the aim of deepening our understanding of the fascinating relationship between the gut microbiome and the central nervous system. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. From Development to Place in Therapy of Lorlatinib for the Treatment of ALK and ROS1 Rearranged Non-Small Cell Lung Cancer (NSCLC).
- Author
-
Fabbri, Laura, Di Federico, Alessandro, Astore, Martina, Marchiori, Virginia, Rejtano, Agnese, Seminerio, Renata, Gelsomino, Francesco, and De Giglio, Andrea
- Subjects
- *
NON-small-cell lung carcinoma , *CRIZOTINIB , *CLINICAL trials , *ANAPLASTIC large-cell lymphoma , *BLOOD-brain barrier , *BRAIN diseases - Abstract
Following the results of the CROWN phase III trial, the third-generation macrocyclic ALK inhibitor lorlatinib has been introduced as a salvage option after the failure of a first-line TKI in ALK-rearranged NSCLC, while its precise role in the therapeutic algorithm of ROS1 positive disease is still to be completely defined. The ability to overcome acquired resistance to prior generation TKIs (alectinib, brigatinib, ceritinib, and crizotinib) and the high intracranial activity in brain metastatic disease thanks to increased blood–brain barrier penetration are the reasons for the growing popularity and interest in this molecule. Nevertheless, the major vulnerability of this drug resides in a peculiar profile of related collateral events, with neurological impairment being the most conflicting and debated clinical issue. The cognitive safety concern, the susceptibility to heterogeneous resistance pathways, and the absence of a valid alternative in the second line are strongly jeopardizing a potential paradigm shift in this oncogene-addicted disease. So, when prescribing lorlatinib, clinicians must face two diametrically opposed characteristics: a great therapeutic potential without the intrinsic limitations of its precursor TKIs, a cytotoxic activity threatened by suboptimal tolerability, and the unavoidable onset of resistance mechanisms we cannot properly manage yet. In this paper, we give a critical point of view on the stepwise introduction of this promising drug into clinical practice, starting from its innovative molecular and biochemical properties to intriguing future developments, without forgetting its weaknesses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Exploring the Central Mechanisms of Botulinum Toxin in Parkinson's Disease: A Systematic Review from Animal Models to Human Evidence.
- Author
-
Cutrona, Carolina, Marchet, Francesco, Costanzo, Matteo, De Bartolo, Maria Ilenia, Leodori, Giorgio, Ferrazzano, Gina, Conte, Antonella, Fabbrini, Giovanni, Berardelli, Alfredo, and Belvisi, Daniele
- Subjects
- *
BOTULINUM A toxins , *BOTULINUM toxin , *PARKINSON'S disease , *ANIMAL models in research , *CENTRAL nervous system , *SENSORIMOTOR integration - Abstract
Botulinum toxin (BoNT) is an effective and safe therapy for the symptomatic treatment of several neurological disturbances. An important line of research has provided numerous pieces of evidence about the mechanisms of action of BoNT in the central nervous system, especially in the context of dystonia and spasticity. However, only a few studies focused on the possible central effects of BoNT in Parkinson's disease (PD). We performed a systematic review to describe and discuss the evidence from studies focused on possible central effects of BoNT in PD animal models and PD patients. To this aim, a literature search in PubMed and SCOPUS was performed in May 2023. The records were screened according to title and abstract by two independent reviewers and relevant articles were selected for full-text review. Most of the papers highlighted by our review report that the intrastriatal administration of BoNT, through local anticholinergic action and the remodulation of striatal compensatory mechanisms secondary to dopaminergic denervation, induces an improvement in motor and non-motor symptoms in the absence of neuronal loss in animal models of PD. In human subjects, the data are scarce: a single neurophysiological study in tremulous PD patients found that the change in tremor severity after peripheral BoNT administration was associated with improved sensory–motor integration and intracortical inhibition measures. Further clinical, neurophysiological, and neuroimaging studies are necessary to clarify the possible central effects of BoNT in PD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Filtering property of myelinated internode can change neural information representability and might trigger a compensatory action during demyelination.
- Author
-
Das, Sarbani and Maharatna, Koushik
- Subjects
- *
MYELIN proteins , *CENTRAL nervous system , *OLIGODENDROGLIA , *ACTION potentials , *DEMYELINATION , *MYELIN - Abstract
In this paper, for the first time, we showed that an Internode Segment (INS) of a myelinated axon acts as a lowpass filter, and its filter characteristics depend on the number of myelin turns. Consequently, we showed how the representability of a neural signal could be altered with myelin loss in pathological conditions involving demyelinating diseases. Contrary to the traditionally held viewpoint that myelin geometry of an INS is optimised for maximising Conduction Velocity (CV) of Action Potential (AP), our theory provides an alternative viewpoint that myelin geometry of an INS is optimised for maximizing representability of the stimuli a fibre is meant to carry. Subsequently, we show that this new viewpoint could explain hitherto unexplained experimentally observed phenomena such as, shortening of INS length during demyelination and remyelination, and non-uniform distribution of INS in the central nervous system fibres and associated changes in diameter of nodes of ranvier along an axon. Finally, our theory indicates that a compensatory action could take place during demyelination up to a certain number of loss of myelin turns to preserve the neural signal representability by simultaneous linear scaling of the length of an INS and the inner radius of the fibre. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
26. Signature methods for brain-computer interfaces.
- Author
-
Xu, Xiaoqi, Lee, Darrick, Drougard, Nicolas, and Roy, Raphaëlle N.
- Subjects
- *
BRAIN-computer interfaces , *PERIPHERAL nervous system , *ITERATED integrals , *MOTOR imagery (Cognition) , *CENTRAL nervous system - Abstract
Brain-computer interfaces (BCIs) allow direct communication between one's central nervous system and a computer without any muscle movement hence by-passing the peripheral nervous system. They can restore disabled people's ability to interact with their environment, e.g. communication and wheelchair control. However, to this day their performance is still hindered by the non-stationarity of electroencephalography (EEG) signals, as well as their susceptibility to noise from the users' environment and from their own physiological activity. Moreover, a non-negligible amount of users struggle to use BCI systems based on motor imagery. In this paper, a new method based on the path signature is introduced to tackle this problem by using features which are different from the usual power-based ones. The path signature is a series of iterated integrals computed from a multidimensional path. It is invariant under translation and time reparametrization, which makes it a robust feature for multichannel EEG time series. The performance can be further boosted by combining the path signature with the gold standard Riemannian classifier in the BCI field exploiting the geometric structure of symmetric positive definite (SPD) matrices. The results obtained on publicly available datasets show that the signature method is more robust to inter-user variability than classical ones, especially on noisy and low-quality data. Hence, this study paves the way towards the use of mathematical tools that until now have been neglected, in order to tackle the EEG-based BCI variability issue. It also sheds light on the lead-lag relationship captured by path signature which seems relevant to assess the underlying neural mechanisms. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier.
- Author
-
Malik, Johid Reza, Podany, Anthony T., Khan, Parvez, Shaffer, Christopher L., Siddiqui, Jawed A., Baranowska‐Kortylewicz, Janina, Le, Jennifer, Fletcher, Courtney V., Ether, Sadia Afruz, and Avedissian, Sean N.
- Subjects
- *
BLOOD-brain barrier , *ANTINEOPLASTIC agents , *CANCER chemotherapy , *CENTRAL nervous system , *CHILD mortality , *BRAIN tumors - Abstract
Background: Pediatric brain tumors (PBT) stand as the leading cause of cancer‐related deaths in children. Chemoradiation protocols have improved survival rates, even for non‐resectable tumors. Nonetheless, radiation therapy carries the risk of numerous adverse effects that can have long‐lasting, detrimental effects on the quality of life for survivors. The pursuit of chemotherapeutics that could obviate the need for radiotherapy remains ongoing. Several anti‐tumor agents, including sunitinib, valproic acid, carboplatin, and panobinostat, have shown effectiveness in various malignancies but have not proven effective in treating PBT. The presence of the blood–brain barrier (BBB) plays a pivotal role in maintaining suboptimal concentrations of anti‐cancer drugs in the central nervous system (CNS). Ongoing research aims to modulate the integrity of the BBB to attain clinically effective drug concentrations in the CNS. However, current findings on the interaction of exogenous chemical agents with the BBB remain limited and do not provide a comprehensive explanation for the ineffectiveness of established anti‐cancer drugs in PBT. Methods: We conducted our search for chemotherapeutic agents associated with the blood–brain barrier (BBB) using the following keywords: Chemotherapy in Cancer, Chemotherapy in Brain Cancer, Chemotherapy in PBT, BBB Inhibition of Drugs into CNS, Suboptimal Concentration of CNS Drugs, PBT Drugs and BBB, and Potential PBT Drugs. We reviewed each relevant article before compiling the information in our manuscript. For the generation of figures, we utilized BioRender software. Focus: We focused our article search on chemical agents for PBT and subsequently investigated the role of the BBB in this context. Our search criteria included clinical trials, both randomized and non‐randomized studies, preclinical research, review articles, and research papers. Finding: Our research suggests that, despite the availability of potent chemotherapeutic agents for several types of cancer, the effectiveness of these chemical agents in treating PBT has not been comprehensively explored. Additionally, there is a scarcity of studies examining the role of the BBB in the suboptimal outcomes of PBT treatment, despite the effectiveness of these drugs for other types of tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
28. Cognitive decline as the main manifestation of diabetic striatal disease but without involuntary movements: a case report.
- Author
-
Li, He, Cheng, YiRan, Tang, Wei, Hu, YiBin, Jia, GeHui, Wu, Tong, and Wang, KangFeng
- Subjects
- *
COGNITION disorders , *CENTRAL nervous system , *CAUDATE nucleus , *GLYCEMIC control , *BASAL ganglia , *HYPERGLYCEMIA , *MOVEMENT disorders - Abstract
Diabetic striatopathy (DS) is a rare central nervous system complication of diabetes mellitus, characterized mainly by non-ketotic hyperglycemia and lateralized involuntary movements. Patients with diabetic striatopathy manifested solely by subacute cognitive decline were rarely reported. In this paper, we report a patient with DS who presented solely with subacute cognitive decline without involuntary movements, and cranial CT showed bilateral high density in the basal ganglia. In contrast, SWI showed microhemorrhages in the right caudate nucleus head. After one week of treatment, including glycemic control, the patient showed significant improvement in cognitive function, while a repeat cranial CT showed improved hyperdensity in the right basal ganglia region. 1 month later, at telephone follow-up, the patient's symptoms did not recur. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
29. Hyponatremia in patients with arterial hypertension: pathophysiology and management.
- Author
-
Adamczak, Marcin, Surma, Stanisław, and Więcek, Andrzej
- Subjects
- *
HYPONATREMIA , *HYPERTENSION , *VASCULAR endothelial cells , *DEMYELINATION , *CENTRAL nervous system , *EXTRACELLULAR space - Abstract
Sodium is the main cation in the extracellular space. In physiological conditions, sodium concentration in plasma is 135-145 mmol/l. The kidneys play the most important role in the regulation of sodium homeostasis. In recent years, a significant role of glycosaminoglycans, localized mainly in the subcutaneous tissue, and the role of glycocalyx on the surface of vascular endothelial cells, have been documented in the regulation of sodium metabolism. Hyponatremia is defined by a plasma sodium concentration lower than 135 mmol/l. Hyponatremia significantly worsens the prognosis of patients with different chronic diseases. In patients with arterial hypertension, the risk of hyponatremia is 1.5 times higher than in the general population. One of the causes of hyponatremia in patients with arterial hypertension is the use of thiazide or thiazide-like diuretics. The symptoms of hyponatremia are caused mainly by the swelling of cells in the central nervous system. Treatment of hyponatremia depends on the degree and duration (acute or chronic) of hyponatremia as well as presence of clinical symptoms. Too rapid correction of hyponatremia might result in a potentially fatal osmotic demyelinating syndrome. In the present review paper, pathophysiology and management of hyponatremia in patients with arterial hypertension are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
30. Detrimental Effects of ApoE ε4 on Blood–Brain Barrier Integrity and Their Potential Implications on the Pathogenesis of Alzheimer's Disease.
- Author
-
Kirchner, Kevin, Garvert, Linda, Kühn, Luise, Bonk, Sarah, Grabe, Hans Jörgen, and Van der Auwera, Sandra
- Subjects
- *
BLOOD-brain barrier , *ALZHEIMER'S disease , *APOLIPOPROTEIN E , *CENTRAL nervous system , *OLDER people , *NEURODEGENERATION - Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease representing the most common type of dementia in older adults. The major risk factors include increased age, genetic predisposition and socioeconomic factors. Among the genetic factors, the apolipoprotein E (ApoE) ε4 allele poses the greatest risk. Growing evidence suggests that cerebrovascular dysfunctions, including blood–brain barrier (BBB) leakage, are also linked to AD pathology. Within the scope of this paper, we, therefore, look upon the relationship between ApoE, BBB integrity and AD. In doing so, both brain-derived and peripheral ApoE will be considered. Despite the considerable evidence for the involvement of brain-derived ApoE ε4 in AD, information about the effect of peripheral ApoE ε4 on the central nervous system is scarce. However, a recent study demonstrated that peripheral ApoE ε4 might be sufficient to impair brain functions and aggravate amyloid-beta pathogenesis independent from brain-based ApoE ε4 expression. Building upon recent literature, we provide an insight into the latest research that has enhanced the understanding of how ApoE ε4, secreted either in the brain or the periphery, influences BBB integrity and consequently affects AD pathogenesis. Subsequently, we propose a pathway model based on current literature and discuss future research perspectives. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
31. A bicycle can be balanced by stochastic optimal feedback control but only with accurate speed estimates.
- Author
-
Maris, Eric
- Subjects
- *
STOCHASTIC control theory , *CYCLING , *CYCLISTS , *CENTRAL nervous system , *COVARIANCE matrices - Abstract
Balancing a bicycle is typical for the balance control humans perform as a part of a whole range of behaviors (walking, running, skating, skiing, etc.). This paper presents a general model of balance control and applies it to the balancing of a bicycle. Balance control has both a physics (mechanics) and a neurobiological component. The physics component pertains to the laws that govern the movements of the rider and his bicycle, and the neurobiological component pertains to the mechanisms via which the central nervous system (CNS) uses these laws for balance control. This paper presents a computational model of this neurobiological component, based on the theory of stochastic optimal feedback control (OFC). The central concept in this model is a computational system, implemented in the CNS, that controls a mechanical system outside the CNS. This computational system uses an internal model to calculate optimal control actions as specified by the theory of stochastic OFC. For the computational model to be plausible, it must be robust to at least two inevitable inaccuracies: (1) model parameters that the CNS learns slowly from interactions with the CNS-attached body and bicycle (i.e., the internal noise covariance matrices), and (2) model parameters that depend on unreliable sensory input (i.e., movement speed). By means of simulations, I demonstrate that this model can balance a bicycle under realistic conditions and is robust to inaccuracies in the learned sensorimotor noise characteristics. However, the model is not robust to inaccuracies in the movement speed estimates. This has important implications for the plausibility of stochastic OFC as a model for motor control. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
32. CD8 Encephalitis in HIV: A Review of This Emerging Entity.
- Author
-
Shenoy, Aniruddh, Marwaha, Pavan Kaur, and Worku, Dominic Adam
- Subjects
- *
CD8 antigen , *ENCEPHALITIS , *HIV , *NEUROLOGICAL disorders , *PROGNOSIS - Abstract
Introduction: Encephalitis is a life-threatening neurological condition with multiple causes in the setting of Human Immunodeficiency Virus (HIV). CD8 Encephalitis (CD8E) is a newly recognised condition which can present in an acute manner, with pertinent features including classical radiological findings with an intense brain parenchymal infiltration of CD8+ T cells. This review attempted to clarify the symptomatology, distribution and determinants of this condition, as well as to examine its vast unknowns. Methods: A literature review was undertaken in July 2022, utilising the PubMed and Google Scholar databases. Papers published between 2006–2022 were reviewed. Eighteen papers, totalling 57 patients, were found and analysed. Statistical analysis was undertaken using Chi-squared and Wilcoxon rank-sum tests as appropriate, with p < 0.05 deemed significant. Results: In this review, 57 patients were identified, with a female (61%, 34/56) and Black African (70%, 40/57) preponderance. Females were more likely to present with headache (p = 0.006), and headache was more likely to be present in those who died (p = 0.02). There was no statistically significant association between baseline CD4 count (p = 0.079) and viral load (p = 0.72) with disease outcome. Overall, 77% (41/53) of patients had classical imaging findings, including bilateral gadolinium-enhancing punctate and perivascular white matter lesions. However, many patients (23/57) required a brain biopsy as part of their diagnostic workup. Corticosteroid treatment was commonly prescribed in patients (64%, 35/55) and had a mortality benefit, with an overall survival in this group of 71% (p = 0.0008). In those who died, median survival was 5.5 months. In rare instances, recurrence of the disease was noted, which responded poorly to treatment. Discussion: CD8E represents a new and complex condition with few risk factors identified for its occurrence. The presenting symptoms are broad, but headache appears to be more common in females and more significantly associated with death. Though rare, CD8E is likely under-diagnosed, possibly due to overlapping features with other illnesses and lack of physician experience in its recognition and management. Corticosteroids demonstrate a clear mortality benefit, but more studies are required to determine their optimal dosing and duration, as well as the use of steroid-sparing agents. Further reviews should help to better determine the risk factors for the condition, as well as non-invasive biomarkers, to aid in diagnosis and help to predict poor prognosis and disease recurrence. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
33. From Homeostasis to Pathology: Decoding the Multifaceted Impact of Aquaporins in the Central Nervous System.
- Author
-
Toader, Corneliu, Tataru, Calin Petru, Florian, Ioan-Alexandru, Covache-Busuioc, Razvan-Adrian, Dumitrascu, David-Ioan, Glavan, Luca Andrei, Costin, Horia Petre, Bratu, Bogdan-Gabriel, and Ciurea, Alexandru Vlad
- Subjects
- *
CENTRAL nervous system , *AQUAPORINS , *ALZHEIMER'S disease , *HOMEOSTASIS , *WATER-electrolyte balance (Physiology) , *PARKINSON'S disease , *NEUROMYELITIS optica - Abstract
Aquaporins (AQPs), integral membrane proteins facilitating selective water and solute transport across cell membranes, have been the focus of extensive research over the past few decades. Particularly noteworthy is their role in maintaining cellular homeostasis and fluid balance in neural compartments, as dysregulated AQP expression is implicated in various degenerative and acute brain pathologies. This article provides an exhaustive review on the evolutionary history, molecular classification, and physiological relevance of aquaporins, emphasizing their significance in the central nervous system (CNS). The paper journeys through the early studies of water transport to the groundbreaking discovery of Aquaporin 1, charting the molecular intricacies that make AQPs unique. It delves into AQP distribution in mammalian systems, detailing their selective permeability through permeability assays. The article provides an in-depth exploration of AQP4 and AQP1 in the brain, examining their contribution to fluid homeostasis. Furthermore, it elucidates the interplay between AQPs and the glymphatic system, a critical framework for waste clearance and fluid balance in the brain. The dysregulation of AQP-mediated processes in this system hints at a strong association with neurodegenerative disorders such as Parkinson's Disease, idiopathic normal pressure hydrocephalus, and Alzheimer's Disease. This relationship is further explored in the context of acute cerebral events such as stroke and autoimmune conditions such as neuromyelitis optica (NMO). Moreover, the article scrutinizes AQPs at the intersection of oncology and neurology, exploring their role in tumorigenesis, cell migration, invasiveness, and angiogenesis. Lastly, the article outlines emerging aquaporin-targeted therapies, offering a glimpse into future directions in combatting CNS malignancies and neurodegenerative diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
34. CBMC: A Biomimetic Approach for Control of a 7-Degree of Freedom Robotic Arm.
- Author
-
Li, Qingkai, Pang, Yanbo, Wang, Yushi, Han, Xinyu, Li, Qing, and Zhao, Mingguo
- Subjects
- *
REINFORCEMENT learning , *CENTRAL nervous system , *ROBOTICS , *CEREBRAL cortex , *SPINAL cord , *NEURAL circuitry - Abstract
Many approaches inspired by brain science have been proposed for robotic control, specifically targeting situations where knowledge of the dynamic model is unavailable. This is crucial because dynamic model inaccuracies and variations can occur during the robot's operation. In this paper, inspired by the central nervous system (CNS), we present a CNS-based Biomimetic Motor Control (CBMC) approach consisting of four modules. The first module consists of a cerebellum-like spiking neural network that employs spiking timing-dependent plasticity to learn the dynamics mechanisms and adjust the synapses connecting the spiking neurons. The second module constructed using an artificial neural network, mimicking the regulation ability of the cerebral cortex to the cerebellum in the CNS, learns by reinforcement learning to supervise the cerebellum module with instructive input. The third and last modules are the cerebral sensory module and the spinal cord module, which deal with sensory input and provide modulation to torque commands, respectively. To validate our method, CBMC was applied to the trajectory tracking control of a 7-DoF robotic arm in simulation. Finally, experiments are conducted on the robotic arm using various payloads, and the results of these experiments clearly demonstrate the effectiveness of the proposed methodology. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
35. The Impact of Microbiota on the Gut–Brain Axis: Examining the Complex Interplay and Implications.
- Author
-
Chaudhry, Tuba Shahid, Senapati, Sidhartha Gautam, Gadam, Srikanth, Mannam, Hari Priya Sri Sai, Voruganti, Hima Varsha, Abbasi, Zainab, Abhinav, Tushar, Challa, Apurva Bhavana, Pallipamu, Namratha, Bheemisetty, Niharika, and Arunachalam, Shivaram P.
- Subjects
- *
ENTERIC nervous system , *CENTRAL nervous system , *GASTROINTESTINAL system , *LITERATURE reviews , *SENSORY perception , *SUBMUCOUS plexus - Abstract
The association and interaction between the central nervous system (CNS) and enteric nervous system (ENS) is well established. Essentially ENS is the second brain, as we call it. We tried to understand the structure and function, to throw light on the functional aspect of neurons, and address various disease manifestations. We summarized how various neurological disorders influence the gut via the enteric nervous system and/or bring anatomical or physiological changes in the enteric nervous system or the gut and vice versa. It is known that stress has an effect on Gastrointestinal (GI) motility and causes mucosal erosions. In our literature review, we found that stress can also affect sensory perception in the central nervous system. Interestingly, we found that mutations in the neurohormone, serotonin (5-HT), would result in dysfunctional organ development and further affect mood and behavior. We focused on the developmental aspects of neurons and cognition and their relation to nutritional absorption via the gastrointestinal tract, the development of neurodegenerative disorders in relation to the alteration in gut microbiota, and contrariwise associations between CNS disorders and ENS. This paper further summarizes the synergetic relation between gastrointestinal and neuropsychological manifestations and emphasizes the need to include behavioral therapies in management plans. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
36. Cranial Investigations of Crested Porcupine (Hystrix cristata) by Anatomical Cross-Sections and Magnetic Resonance Imaging.
- Author
-
Morales-Bordon, Daniel, Encinoso, Mario, Arencibia, Alberto, and Jaber, José Raduan
- Subjects
- *
MAGNETIC resonance imaging , *PORCUPINES , *DIAGNOSTIC imaging , *CENTRAL nervous system - Abstract
Simple Summary: Advanced imaging diagnostic techniques, such as magnetic resonance imaging with anatomical sections, were used to evaluate the head of the crested porcupine (Hystrix cristata). These techniques were very helpful to delineate the main formations that compose the central nervous system (CNS), as well as its associated structures. To the authors' knowledge, the present study is the first to describe this area using anatomical sections and magnetic resonance imaging (MRI) in crested porcupines. This paper aimed to describe an atlas of the crested porcupine (Hystrix cristata) head by applying advanced imaging techniques such as MRI. Furthermore, by combining the images acquired through these techniques with anatomical sections, we obtained an adequate description of the structures that form the CNS and associated structures of this species. This anatomical information could serve as a valuable diagnostic tool for the clinical evaluation of different pathological processes in porcupines, such as abscesses, skull malformations, fractures, and neoplasia. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
37. Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects.
- Author
-
Alkahtani, Saad, AL-Johani, Norah S., and Alarifi, Saud
- Subjects
- *
NEUROLOGICAL disorders , *BLOOD-brain barrier , *CENTRAL nervous system , *SCIENTIFIC community , *BRAIN damage , *CEREBROVASCULAR disease - Abstract
Neurodegenerative diseases (NDs) are a major cause of disability and are related to brain development. The neurological signs of brain lesions can vary from mild clinical shortfalls to more delicate and severe neurological/behavioral symptoms and learning disabilities, which are progressive. In this paper, we have tried to summarize a collective view of various NDs and their possible therapeutic outcomes. These diseases often occur as a consequence of the misfolding of proteins post-translation, as well as the dysfunctional trafficking of proteins. In the treatment of neurological disorders, a challenging hurdle to cross regarding drug delivery is the blood–brain barrier (BBB). The BBB plays a unique role in maintaining the homeostasis of the central nervous system (CNS) by exchanging components between the circulations and shielding the brain from neurotoxic pathogens and detrimental compounds. Here, we outline the current knowledge about BBB deterioration in the evolving brain, its origin, and therapeutic interventions. Additionally, we summarize the physiological scenarios of the BBB and its role in various cerebrovascular diseases. Overall, this information provides a detailed account of BBB functioning and the development of relevant treatments for neurological disorders. This paper will definitely help readers working in the field of neurological scientific communities. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
38. Application of Robotic Recovery Techniques to Stroke Survivors—Bibliometric Analysis.
- Author
-
Uivarosan, Diana, Bungau, Simona Gabriela, Nistor-Cseppento, Carmen Delia, Negru, Paul Andrei, Bungau, Alexa Florina, Sabau, Anca Maria, Tit, Delia Mirela, Uivaraseanu, Bogdan, and Radu, Andrei-Flavius
- Subjects
- *
BIBLIOMETRICS , *STROKE patients , *ROBOTICS , *CENTRAL nervous system , *SCIENCE databases - Abstract
Stroke is a significant disability and death cause worldwide and is conventionally defined as a neurological impairment relating to the intense focal harm of the central nervous system (CNS) by vascular causative components. Although the applicability of robotic rehabilitation is a topic with considerable practical significance because it has produced noticeably higher improvements in motor function than regular (physical and occupational) therapy and exempted the therapists, most of the existing bibliometric papers were not focused on stroke survivors. Additionally, a modular system is designed by joining several medical end-effector devices to a single limb segment, which addresses the issue of potentially dangerous pathological compensatory motions. Searching the Web of Science database, 31,930 papers were identified, and using the VOSviewer software and science mapping technology, data were extracted on the most prolific countries, the connections between them, the most valuable journals according to certain factors, their average year of publication, the most influential papers, and the most relevant topical issues (bubble map of term occurrence). The most prolific country in the analyzed field and over the entire period evaluated (1975–2022) is the United States, and the most prolific journal is Neurorehabilitation and Neural Repair, observing a marked increase in the three periods of scientific interest for this field. The present paper assesses numerous scientific publications to provide, through statistical interpretation of the data, a detailed description of the use of robotic rehabilitation in stroke survivors. The findings may aid scientists, academics, and clinicians in establishing precise goals in the optimization of the management of stroke survivors via robotic rehabilitation, but also through easier access to scientifically validated literature. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
39. Adverse Effects of Methylene Blue on the Central Nervous System.
- Author
-
Laszlo Vutskits
- Subjects
- *
METHYLENE blue , *INDICATORS & test-papers , *CENTRAL nervous system , *NERVOUS system , *PARATHYROID glands - Abstract
BACKGROUND:: An increasing number of clinical observations suggest adverse neurologic outcome after methylene blue (MB) infusion in the setting of parathyroid surgery. Hence, the aim of the current study was to investigate the potentially neurotoxic effects of MB using a combination of in vivo and in vitro experimental approaches. METHODS:: Isoflurane-anesthetized adult rats were used to evaluate the impact of a single bolus intravascular administration of MB on systemic hemodynamic responses and on the minimum alveolar concentration (MAC) of isoflurane using the tail clamp test. In vivo, MB-induced cell death was evaluated 24 h after MB administration using Fluoro-Jade B staining and activated caspase-3 immunohistochemistry. In vitro, neurotoxic effects of MB were examined in hippocampal slice cultures by measuring excitatory field potentials as well as propidium iodide incorporation after MB exposure. The impact of MB on dendritic arbor was evaluated in differentiated single cell neuronal cultures. RESULTS:: Bolus injections of MB significantly reduced isoflurane MAC and initiated widespread neuronal apoptosis. Electrophysiologic recordings in hippocampal slices revealed a rapid suppression of evoked excitatory field potentials by MB, and this was associated with a dose-dependent effect of this drug on cell death. Dose–response experiments in single cell neuronal cultures revealed that a 2-h-long exposure to MB at non–cell-death-inducing concentrations could still induce significant retraction of dendritic arbor. CONCLUSIONS:: These results suggest that MB exerts neurotoxic effects on the central nervous system and raise questions regarding the safety of using this drug at high doses during parathyroid gland surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
40. Investigation on Efficient Deep Learning Framework for Spinal Deformities: A Review Approach.
- Author
-
Koban, Mamta S., Singh, Vijay P., and Bodade, Rajesh
- Subjects
- *
DEEP learning , *SPINE abnormalities , *CENTRAL nervous system , *HUMAN body , *SPINAL cord , *BRAIN stem - Abstract
The present paper is related to the survey on the Investigation on Efficient Deep Learning Framework for Sipal Deformities. In this paper, some selected papers are taken for the investigation to find research gaps or extensions of existing research in the selected domain. The central nervous system is the most significant processing unit in the human body, and it is located in the central nervous system. Management and control of all the key organs from head to toe including eye blinking, breathing, heart pumping and movement of motion including bending and twisting are all managed and controlled by this system. The central nervous system is comprised of two primary organs: the brain, which is the most important, and the spinal cord, which is the second most important. The brain stem serves as the spinal column's beginning point. In its most basic form, the spinal cord is a delicate vertical pipe with a solid texture that includes a collection of nerves and tissues. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
41. Folate Pathway Gene Single Nucleotide Polymorphisms and Neural Tube Defects: A Systematic Review and Meta-Analysis.
- Author
-
Almekkawi, Ahmad K., AlJardali, Marwa W., Daadaa, Hicham M., Lane, Alison L., Worner, Ashley R., Karim, Mohammad A., Scheck, Adrienne C., and Frye, Richard E.
- Subjects
- *
SINGLE nucleotide polymorphisms , *FOLIC acid , *NEURAL tube defects , *GENETIC models , *CENTRAL nervous system , *GENES - Abstract
Neural tube defects (NTDs) are congenital abnormalities in the central nervous system. The exact etiology of NTDs is still not determined, but several genetic and epigenetic factors have been studied. Folate supplementation during gestation is recommended to reduce the risk of NTDs. In this review we examine single nucleotide polymorphisms (SNPs) of the genes in the folate pathway associated with NTD. We reviewed the literature for all papers discussing both NTDs and SNPs in the folate pathway. Data were represented through five different genetic models. Quality assessment was performed using the Newcastle–Ottawa Scale (NOS) and Cohen's Kappa inter-rater coefficient assessed author agreement. Fifty-nine papers were included. SNPs in MTHFR, MTRR, RFC genes were found to be highly associated with NTD risk. NOS showed that high quality papers were selected, and Kappa Q-test was 0.86. Our combined results support the notion that SNPs significantly influence NTDs across the population, particularly in Asian ethnicity. Additional high-quality research from diverse ethnicities is needed and meta-regression analysis based on a range of criteria may provide a more complete understanding of the role of folate metabolism in NTDs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
42. Motion, Relation, and Passion in Brain Physiological and Cognitive Aging.
- Author
-
Sigmundsson, Hermundur, Dybendal, Benjamin H., and Grassini, Simone
- Subjects
- *
COGNITIVE aging , *AGE , *SCIENTIFIC literature , *CENTRAL nervous system , *OLDER people , *STIMULUS & response (Psychology) - Abstract
The aim of the current paper was to present important factors for keeping the basic structures of a person's brain function, i.e., the grey and white matter, intact. Several lines of evidence have shown that motion, relation, and passion are central factors for preserving the neural system in the grey and white matter during ageing. An active lifestyle has shown to contribute to the development of the central nervous system and to contrast brain ageing. Interpersonal relationships, and interactions, have shown to contribute to complex biological factors that benefit the cognitive resilience to decline. Furthermore, the current scientific literature suggests that passion, strong interest, could be the driving factor motivating individuals to learn new things, thus influencing the development and maintenance of the neural functional network over time. The present theoretical perspective paper aims to convey several key messages: (1) brain development is critically affected by lifestyle; (2) physical training allows one to develop and maintain brain structures during ageing, and may be one of the keys for good quality of life as an older person; (3) diverse stimuli are a key factor in maintaining brain structures; (4) motion, relation, and passion are key elements for contrasting the loss of the grey and white matter of the brain. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
43. Pharmacological Potential of Flavonoids against Neurotropic Viruses.
- Author
-
Castro e Silva, Juliana Helena, Souza, Jéssica Teles, Schitine, Clarissa, Júnior, Aníbal de Freitas Santos, Bastos, Eduardo Muniz Santana, and Costa, Silvia Lima
- Subjects
- *
FLAVONOIDS , *COVID-19 , *HEPATITIS C , *CENTRAL nervous system ,CENTRAL nervous system infections - Abstract
Flavonoids are a group of natural compounds that have been described in the literature as having anti-inflammatory, antioxidant, and neuroprotective compounds. Although they are considered versatile molecules, little has been discussed about their antiviral activities for neurotropic viruses. Hence, the present study aimed to investigate the pharmacological potential of flavonoids in the face of viruses that can affect the central nervous system (CNS). We carried out research from 2011 to 2021 using the Pubmed platform. The following were excluded: articles not in the English language, letters to editors, review articles and papers that did not include any experimental or clinical tests, and papers that showed antiviral activities against viruses that do not infect human beings. The inclusion criteria were in silico predictions and preclinical pharmacological studies, in vitro, in vivo and ex vivo, and clinical studies with flavonoids, flavonoid fractions and extracts that were active against neurotropic viruses. The search resulted in 205 articles that were sorted per virus type and discussed, considering the most cited antiviral activities. Our investigation shows the latest relevant data about flavonoids that have presented a wide range of actions against viruses that affect the CNS, mainly influenza, hepatitis C and others, such as the coronavirus, enterovirus, and arbovirus. Considering that these molecules present well-known anti-inflammatory and neuroprotective activities, using flavonoids that have demonstrated both neuroprotective and antiviral effects could be viewed as an alternative for therapy in the course of CNS infections. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
44. Cannabidiol-Loaded Nanoparticles Based on Crosslinked Starch: Anti-Inflammatory Activity and Improved Nose-to-Brain Delivery.
- Author
-
Eydelman, Ilya, Zehavi, Na'ama, Feinshtein, Valeria, Kumar, Dinesh, Ben-Shabat, Shimon, and Sintov, Amnon C.
- Subjects
- *
ANTI-inflammatory agents , *STARCH , *CELL culture , *NANOMEDICINE , *INTRANASAL administration , *CORNSTARCH , *CENTRAL nervous system , *NANOPARTICLES - Abstract
Cannabidiol (CBD) has previously been shown to inhibit inflammatory cytokine production in both in vitro and in vivo studies of neurodegenerative diseases. To date, the CBD treatment of these diseases by quantitative targeting directly to the brain is one of the greatest challenges. In this paper, we present a new particulate system capable of delivering CBD into the brain via the intranasal route. Intranasal administration of CBD-loaded starch nanoparticles resulted in higher levels of cannabidiol in the brain compared to an identically administered cannabidiol solution. The production and the characterization of starch-based nanoparticles was reported, as well as the evaluation of their penetration and anti-inflammatory activity in cells. Cannabidiol-loaded starch nanoparticles were prepared by crosslinking with divanillin, using the nanoprecipitation method. Evaluation of the anti-inflammatory activity in vitro was performed using the BV2 microglia cell line. The starch nanoparticles appeared under electron microscopy in clusters sized approximately 200 nm in diameter. In cultures of lipopolysaccharide-induced inflamed BV2 cells, the cannabidiol-loaded starch nanoparticles demonstrated low toxicity while effectively reducing nitric oxide production and IL-6 levels. The anti-inflammatory effect was comparable to that of a glucocorticoid. Starch-based nanoparticle formulations combined with intranasal administration may provide a suitable platform for efficacious cannabidiol delivery and activity in the central nervous system. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. Current advances in nose to brain drug delivery.
- Author
-
S., Venkatesh Prasad, Sudheer, Preethi, and Shetty, Kannika Belludi Chandrashekhar
- Subjects
- *
BLOOD-brain barrier , *INTRANASAL administration , *NASAL cavity , *NOSE , *DRUG delivery systems , *CENTRAL nervous system - Abstract
The systemic treatments are not able to assure adequate drug concentration in the brain tissues in many neurological disorders due to the biological barriers such as the blood-brain barrier. Therefore, drug delivery systems can directly target the brain cells in a noninvasive means and bring about adequate drug in the brain is the focus in many of central nervous system (CNS) diseases. Perhaps the intranasal route and the direct anatomical connection between the nasal cavity and the brain can be supportive in the direct entry of therapeutic agents into the brain. This review paper is an insight into various considerations involved in the nose to brain drug delivery, such as the pros and cons of intranasal delivery, the anatomical and physiological features of the nose, various pathways, mechanisms of drug transport, disease perspectives, approaches to enhance the drug absorption with brief emphasis on types, and examples of agents used and advents in the nose to brain drug delivery. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
46. Perspectives and Implications of Coanda Effect in Aneurysms.
- Author
-
Saceleanu, Vicentiu-Mircea, Covache-Busuioc, Razvan-Adrian, Glavan, Luca-Andrei, Corlatescu, Antonio-Daniel, and Ciurea, Alexandru Vlad
- Subjects
- *
ANEURYSMS , *INTRACRANIAL aneurysms , *FLUID mechanics , *BLOOD flow , *CENTRAL nervous system - Abstract
It is yet unknown how the formation of an aneurysm inside the human body occurs. Thus, understanding and analyzing the Coanda effect will result in a better overview of the overall fluid mechanics that develop inside such a structure, leading not only to better treatment plans, but also to diminished postoperative risks. This paper presents how the fluid behaves in this situation, and takes into consideration how this physical phenomenon influences the hemodynamics inside numerous anatomical regions, located in the central nervous system, where aneurysms usually develop. Analyzing the three main areas in which cerebral aneurysms form, the Coanda effect can potentially lead to the rupture of the aneurysm by changing the blood flow trajectory; this should be taken into consideration when choosing a treatment plan, especially in postoperative care. In addition, there are other factors that can influence the evolution of an aneurysm, such as its shape, size, localization and the patient's health condition. Understanding and analyzing the Coanda effect will result in a better overview of the overall fluid mechanics that develop inside such a structure, leading not only to better treatment plans, but also to diminished postoperative risks. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
47. Bilirubin-Induced Transcriptomic Imprinting in Neonatal Hyperbilirubinemia.
- Author
-
Llido, John Paul, Fioriti, Emanuela, Pascut, Devis, Giuffrè, Mauro, Bottin, Cristina, Zanconati, Fabrizio, Tiribelli, Claudio, and Gazzin, Silvia
- Subjects
- *
NEONATAL jaundice , *PARIETAL lobe , *CENTRAL nervous system , *TRANSCRIPTOMES , *NEURAL development - Abstract
Simple Summary: Severe neonatal hyperbilirubinemia may damage the brain, leading to motor, cognitive, and auditory abnormalities. We recently discovered that bilirubin might act by controlling the genetic developmental program of the cerebellum, a region of the brain well known to be susceptible to bilirubin-induced damage. In this paper, we expand the study of the potential impact of bilirubin in the control of postnatal brain development to brain regions better correlating with human symptoms. The maximal abnormalities of structure and cell shape (histology) were detected 9 days after birth, fully recovering later on. Differently, the analysis of the gene expression revealed transient alterations (early after birth, then recovering) in the hippocampus (memory, learning, and cognition) and inferior colliculi (auditory functions), but permanent (until adulthood) changes in the areas of the brain involved in the control of movements, information confirmed by the abnormal results on the behavioral tests. These new findings are well in agreement with the clinic and open a way for better deciphering the neurotoxic features of bilirubin neurotoxicity and potential therapeutic approaches. Recent findings indicated aberrant epigenetic control of the central nervous system (CNS) development in hyperbilirubinemic Gunn rats as an additional cause of cerebellar hypoplasia, the landmark of bilirubin neurotoxicity in rodents. Because the symptoms in severely hyperbilirubinemic human neonates suggest other regions as privileged targets of bilirubin neurotoxicity, we expanded the study of the potential impact of bilirubin on the control of postnatal brain development to regions correlating with human symptoms. Histology, transcriptomic, gene correlation, and behavioral studies were performed. The histology revealed widespread perturbation 9 days after birth, restoring in adulthood. At the genetic level, regional differences were noticed. Bilirubin affected synaptogenesis, repair, differentiation, energy, extracellular matrix development, etc., with transient alterations in the hippocampus (memory, learning, and cognition) and inferior colliculi (auditory functions) but permanent changes in the parietal cortex. Behavioral tests confirmed the presence of a permanent motor disability. The data correlate well both with the clinic description of neonatal bilirubin-induced neurotoxicity, as well as with the neurologic syndromes reported in adults that suffered neonatal hyperbilirubinemia. The results pave the way for better deciphering the neurotoxic features of bilirubin and evaluating deeply the efficacy of new therapeutic approaches against the acute and long-lasting sequels of bilirubin neurotoxicity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
48. MicroRNA (miRNA) Complexity in Alzheimer's Disease (AD).
- Author
-
Lukiw, Walter J.
- Subjects
- *
ALZHEIMER'S disease , *MESSENGER RNA , *MICRORNA , *NON-coding RNA , *GENETIC regulation , *CENTRAL nervous system - Abstract
Simple Summary: Alzheimer's disease (AD) is a progressive, age-related neurodegenerative disorder representing the most common cause of senile dementia and neurological dysfunction in our aging domestic population. MicroRNAs (miRNAs) are a small family of non-coding single-stranded RNAs (ssRNAs) that function in complex interactive networks to direct the post-transcriptional repression of messenger RNA (mRNA)-encoded genetic information. Current evidence suggests that these ssRNAs perform an important regulatory role in the expression of genes in the AD-affected brain and central nervous system (CNS). This review paper will focus on recent studies, developments and advancements in our appreciation and understanding of the complexity of miRNA signaling in AD-affected brain hippocampal CA1 compared to age- and gender-matched controls. AD is a complex, progressive, age-related neurodegenerative disorder representing the most common cause of senile dementia and neurological dysfunction in our elderly domestic population. The widely observed heterogeneity of AD is a reflection of the complexity of the AD process itself and the altered molecular-genetic mechanisms operating in the diseased human brain and CNS. One of the key players in this complex regulation of gene expression in human pathological neurobiology are microRNAs (miRNAs) that, through their actions, shape the transcriptome of brain cells that normally associate with very high rates of genetic activity, gene transcription and messenger RNA (mRNA) generation. The analysis of miRNA populations and the characterization of their abundance, speciation and complexity can further provide valuable clues to our molecular-genetic understanding of the AD process, especially in the sporadic forms of this common brain disorder. Current in-depth analyses of high-quality AD and age- and gender-matched control brain tissues are providing pathophysiological miRNA-based signatures of AD that can serve as a basis for expanding our mechanistic understanding of this disorder and the future design of miRNA- and related RNA-based therapeutics. This focused review will consolidate the findings from multiple laboratories as to which are the most abundant miRNA species, both free and exosome-bound in the human brain and CNS, which miRNA species appear to be the most prominently affected by the AD process and review recent developments and advancements in our understanding of the complexity of miRNA signaling in the hippocampal CA1 region of AD-affected brains. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
49. Computer study of metric perturbations impinging on coupled axon tracts.
- Author
-
Chawla, Aman and Morgera, Salvatore Domenic
- Subjects
- *
CENTRAL nervous system , *GRAVITATIONAL waves , *COMPUTER simulation , *COMPUTERS , *SPACETIME - Abstract
Metric perturbations are deviations from a homogeneous spacetime background. In this paper, the authors extend an earlier investigation by using high-precision computer simulations and show that there is definite impact of metric perturbations, that is, gravitational radiation, on the time-coded information conducted by a tract of neural axons as found in the human central nervous system. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
50. Future Perspective for ALK-Positive Anaplastic Large Cell Lymphoma with Initial Central Nervous System (CNS) Involvement: Could Next-Generation ALK Inhibitors Replace Brain Radiotherapy for the Prevention of Further CNS Relapse?
- Author
-
Tanaka, Makito, Miura, Hiroki, Ishimaru, Soichiro, Furukawa, Gen, Kawamura, Yoshiki, Kozawa, Kei, Yamada, Seiji, Ito, Fumitaka, Kudo, Kazuko, and Yoshikawa, Tetsushi
- Subjects
- *
ANAPLASTIC large-cell lymphoma , *CENTRAL nervous system , *CYTARABINE , *ANAPLASTIC lymphoma kinase , *CENTRAL nervous system injuries , *RADIATION injuries , *SPINAL infusions - Abstract
Central nervous system (CNS) involvement in anaplastic large cell lymphoma (ALCL) at diagnosis is rare and leads to poor prognosis with the use of the standard ALCL99 protocol alone. CNS-directed intensive chemotherapy, such as an increased dose of intravenous MTX, increased dose of dexamethasone, intensified intrathecal therapy, and high-dose cytarabine, followed by cranial irradiation, has been shown to improve survival in this population. In this paper, the authors describe a 14-year-old male with an intracranial ALCL mass at onset who received CNS-directed chemotherapy followed by 23.4 Gy of whole-brain irradiation. After the first systemic relapse, the CNS-penetrating ALK inhibitor, alectinib, was applied; it has successfully maintained remission for 18 months without any adverse events. CNS-penetrating ALK inhibitor therapy might prevent CNS relapse in pediatric ALK-positive ALCL. Next-generation ALK inhibitors could be introduced as a promising treatment option, even for primary ALCL with CNS involvement, which could lead to the omission of cranial irradiation and avoid radiation-induced sequalae. Further evidence of CNS-penetrating ALK inhibitor combined therapy for primary ALK-positive ALCL is warranted to reduce radiation-induced sequalae in future treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.